Opti Capital Management »

Pacira Biosciences shares owned by Opti Capital Management

Quarter-by-quarter ownership of Pacira Biosciences shares owned by Opti Capital Management from 13F filings

Historical chart of Opti Capital Management investment in Pacira Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Pacira Biosciences held by Opti Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Biosciences by Opti Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $25M 27M 0.91
2023-06-30 $15B 16M 929.13

More positions owned by Opti Capital Management

Chart Inds Note 1.000%11/1 (Principal)
Insight Enterprises Note 0.750% 2/1 (Principal)
Five9 Note 0.500% 6/0 (Principal)
Novocure Note 11/0 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Sarepta Therapeutics Note 1.250% 9/1 (Principal)
Blackline Note 3/1 (Principal)
Alteryx Note 0.500% 8/0 (Principal)
Hubspot Note 0.375% 6/0 (Principal)
Alarm Com Hldgs Note 1/1 (Principal)
Western Digital Corp. Note 1.500% 2/0 (Principal)
Lyft Note 1.500% 5/1 (Principal)
Booking Holdings Note 0.750% 5/0 (Principal)
Nuvasive Note 0.375% 3/1 (Principal)
3d Sys Corp Del Note 11/1 (Principal)

View all positions for Opti Capital Management

Top funds holding Pacira Biosciences

Wellesley Investment Advisors
Capstone Investment Advisors
Lazard Asset Management
MacKay Shields
Steelhead Partners
Calamos Advisors
III Capital Management
M&g Investment Management
Fort Baker Capital Management
Aequim Alternative Investments
Tenor Capital Management
Palisade Capital Management
Jpmorgan Chase & Co
Credit Suisse
Barclays

View all funds holding Pacira Biosciences